AR

Abdul Rafik Mohamed Asik

Active Director Director DIN 09738708
DIN 09738708 First appointment Sep 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Abdul Rafik Mohamed Asik

Data last updated:

Abdul Rafik Mohamed Asik is a Director at Nicegen Life Sciences Private Limited (since 2022). The company operates in Chemicals. Nicegen Life Sciences Private Limited reported revenue of ₹5.7 Lakh (FY 2025).

DIN 09738708
Primary Designation Director
Industry Chemicals
First Appointment 16 Sep 2022
Oldest Company Age 4 yrs
Largest company Nicegen Life Sciences Private Limited · ₹5.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Sep 20222022₹5.7 Lakh (FY 2025)Active

Board colleagues of Abdul Rafik Mohamed Asik

Directorship timeline

Open interactive timeline →
Nicegen Life Sciences Private Limited
Premium access

Shareholding and investment profile for Abdul Rafik Mohamed Asik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Rafik Mohamed Asik

Abdul Rafik Mohamed Asik currently holds 1 directorship: Nicegen Life Sciences Private Limited (Director, since 16 Sep 2022, revenue ₹5.7 Lakh (FY 2025)).

Abdul Rafik Mohamed Asik was first appointed on 16 Sep 2022 as Director at Nicegen Life Sciences Private Limited.

The current boards of Abdul Rafik Mohamed Asik's companies include Gnanaprakasam (Nicegen Life Sciences Private Limited), Rajendran Elangeswaran (Nicegen Life Sciences Private Limited), Sakthivel Sasikumar (Nicegen Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available